EGFR Mutation-positive NSCLC
1 clinical trials · Condition
◉ Watch EGFR Mutation-positive NSCLC
| Record | Firm | Date |
|---|---|---|
| Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC (NCT07500987) | AstraZeneca | 2026-02-27 |
Track EGFR Mutation-positive NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.